Dial-in Number
| Web session
|
HL7 Antitrust Policy
Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).
Attendees
Please include your organization in your Zoom name.
- Click on your picture/name in Zoom
- Click on rename
- enter <name> - <organization>
| Name | Organization | Present |
|---|---|---|
| Danielle Bancroft | Best Practice Software | |
| Melva Peters | Jenaker Consulting | |
| Jean Duteau (Chair) | Duteau Design | x |
| John Hatem (Scribe) | Independent Consultant | x |
| Scott Robertson | Kaiser Permanente | x |
| Christof Gessner | HL7 Germany | |
| Corey Spears | MITRE | |
| Dave Hill | MITRE | |
| Frank McKinney | POCP | |
| Isaac Vetter | Epic | |
Joseph Quinn (Joe) | Smile Digital Health | x |
| Lawrence Lo | Columbia University HIT Student | |
| Margaret Weiker | NCPDP | |
| Matt Szczepankiewicz | Epic | |
| Peter Sergent | HL7 New Zealand | x |
| Reed D. Gelzer | Trustworthy EHR | |
| Shelly Spiro | Pharmacy HIT Collaborative | x |
| Stephen Chu | ADHA | x |
| Tim McNeil | Surescripts | x |
| Kim Roberts | Pharmacy HIT Collaborative | |
| Phung Matthews | 3M | |
| Jack Brashier | Epic | |
| Emmanuel Obasuyi | ||
| Joel Montavon | PQA | |
| Robb Young | PharmID | |
| Christopher Isong | ||
| Gary Schoettmer | NetRx | |
| Courtney Bland | CVS / Aetna | |
| Mark Neumuth | Aetna | |
| Ed Millikan | FDA | |
| Sanket Raval | CVS / Aetna | |
| James Tcheng | ||
| Peter Muir | ||
| Joe Kelly | Surescripts | |
| Peter Jordan | ||
| Giorgio Cangioli | HL7 Italy | x |
| Jose Costa Teixeira | x | |
| Jeff Shick | USP | |
| Kent Bulza | Artera |
Agenda Items and Notes
Outstanding Action Item List
Meeting Notes from previous meeting
- 2023-01-30 Meeting Notes - Accepted without changes
Project Proposals
Project Proposals in Review - none to review
Project Scope Statements
Project Scope Statements - none to review
External Meeting Review
Catalog Updates (John Hatem)
- Working on trackers, no pharmacy-related issues came up
Workflow Update (John Hatem)
- Updated Definition pattern from tracker. No Pharmacy impact.
Healthcare Product Update (John Hatem)
- Trackers were discussed - no pharmacy impact. Discussed Nutrition Product, BDP, InventoryItem, InventoryReport
EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)
NCPDP Updates (NCPDP Members)
Pharmacist Consult Note (Scott)
- Scott waiting for input.
Pharmacy Templates
- FHIR-20669 issue raised by Giorgio - technical correction
- FHIR-20668 see tracker for issues. Motion to accept proposed solution: Giorgio/Jose motion passed by 9-0-0
- CDA-20494 and CDA-20493 issues. Motion to accept proposal: ScottR/ Shelly motion passed by 9-0-0 See tracker for resolution and details.
Specialty Medication Enrolment IG
- Shelly reported this work is progressing. Developers identified/ seeking funding. This issue may have an international impact e.g. Australian input.
Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)
- Jean has a resource working on making the changes
- working on MedUsage name change completed -
- Feb 24 - all changes from ballot - then will be published as R5
- Jean reported on the status of the work and updates to our trackers. Many are in progress.
- FHIR-38662 discussed, see tracker for details - Motion by: Jose / Scott vote: 9-0-0
Any Other Business
- John reviewed the mapping between Med dispense status and BDP dispense status. Suggestion was to send this to the list serve for input.
- FYI: Shelly reported on some US-CDI work Medication Adherence and Medication Instruction (SIG). Target completion mid April.